Literature DB >> 28238065

Cuprizone-Containing Pellets Are Less Potent to Induce Consistent Demyelination in the Corpus Callosum of C57BL/6 Mice.

Tanja Hochstrasser1, Gianna Lisa Exner2, Stella Nyamoya2,3, Christoph Schmitz2, Markus Kipp2.   

Abstract

The chopper chelator cuprizone serves as a valuable chemical tool to induce consistent and reproducible demyelination in the central nervous system. However, the daily preparation of fresh cuprizone powder mixed in finely ground rodent chow might well be a particular health problem. Alternative methods, such as the fabrication of cuprizone-containing pellets, are available. The effectiveness of this method is, however, not known. In the present study, we compared whether intoxication of C57BL/6 mice with 0.25% cuprizone mixed into ground rodent chow does induce demyelination to a similar extent compared to a cuprizone-pellet intoxication protocol. We found that feeding of 0.25% cuprizone in ground chow provides a strong, well-defined, and reproducible demyelination along with increased accumulation of microglia and axonal damage in the corpus callosum, whereas all analyzed parameters were significantly less distinct in mice fed with cuprizone-containing pellets at an equivalent concentration of cuprizone at week 5. Even a higher concentration of cuprizone in pellet formulation was less potent compared to do so. This study illustrates that the established protocol of cuprizone intoxication (i.e., mixed in ground rodent chow) is the gold standard method to achieve consistent and reproducible demyelination. Why cuprizone loses its effectiveness in pellet formulation needs to be addressed in subsequent studies.

Entities:  

Keywords:  Corpus callosum; Cuprizone; Demyelination; Pellet

Mesh:

Substances:

Year:  2017        PMID: 28238065     DOI: 10.1007/s12031-017-0903-3

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  55 in total

Review 1.  Neuroprotection by estrogen in the brain: the mitochondrial compartment as presumed therapeutic target.

Authors:  Susanne Arnold; Cordian Beyer
Journal:  J Neurochem       Date:  2009-04-29       Impact factor: 5.372

2.  Biochemical effects of cuprizone on mouse liver and heart mitochondria.

Authors:  C L Hoppel; B Tandler
Journal:  Biochem Pharmacol       Date:  1973-09-15       Impact factor: 5.858

3.  Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice.

Authors:  W F Blakemore
Journal:  J Neurocytol       Date:  1972-12

4.  Copper and zinc dismetabolism in the mouse brain upon chronic cuprizone treatment.

Authors:  P Zatta; M Raso; P Zambenedetti; W Wittkowski; L Messori; F Piccioli; P L Mauri; M Beltramini
Journal:  Cell Mol Life Sci       Date:  2005-07       Impact factor: 9.261

5.  Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination.

Authors:  Michele D Binder; Holly S Cate; Anne L Prieto; Dennis Kemper; Helmut Butzkueven; Melissa M Gresle; Tania Cipriani; Vilija G Jokubaitis; Peter Carmeliet; Trevor J Kilpatrick
Journal:  J Neurosci       Date:  2008-05-14       Impact factor: 6.167

Review 6.  Cuprizone-induced demyelination as a tool to study remyelination and axonal protection.

Authors:  Adib Zendedel; Cordian Beyer; Markus Kipp
Journal:  J Mol Neurosci       Date:  2013-05-12       Impact factor: 3.444

7.  Megamitochondria in hepatic and renal disease.

Authors:  A Chedid; W Jao; J Port
Journal:  Am J Gastroenterol       Date:  1980-04       Impact factor: 10.864

8.  Cuprizone treatment induces distinct demyelination, astrocytosis, and microglia cell invasion or proliferation in the mouse cerebellum.

Authors:  Angela Groebe; Tim Clarner; Werner Baumgartner; Jon Dang; Cordian Beyer; Markus Kipp
Journal:  Cerebellum       Date:  2009-03-04       Impact factor: 3.847

9.  Astrogliosis during acute and chronic cuprizone demyelination and implications for remyelination.

Authors:  Norah Hibbits; Jun Yoshino; Tuan Q Le; Regina C Armstrong
Journal:  ASN Neuro       Date:  2012-10-30       Impact factor: 4.146

10.  Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model.

Authors:  Sveinung Fjær; Lars Bø; Arvid Lundervold; Kjell-Morten Myhr; Tina Pavlin; Oivind Torkildsen; Stig Wergeland
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

View more
  17 in total

1.  Visualization of the Breakdown of the Axonal Transport Machinery: a Comparative Ultrastructural and Immunohistochemical Approach.

Authors:  Sebastian Rühling; Franziska Kramer; Selina Schmutz; Sandra Amor; Zhan Jiangshan; Christoph Schmitz; Markus Kipp; Tanja Hochstrasser
Journal:  Mol Neurobiol       Date:  2018-09-21       Impact factor: 5.590

2.  Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.

Authors:  Stefan Esser; Larissa Göpfrich; Kai Bihler; Eugenia Kress; Stella Nyamoya; Simone C Tauber; Tim Clarner; Matthias B Stope; Thomas Pufe; Markus Kipp; Lars-Ove Brandenburg
Journal:  Mol Neurobiol       Date:  2017-12-29       Impact factor: 5.590

3.  Formyl Peptide Receptor 1-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.

Authors:  Kai Bihler; Eugenia Kress; Stefan Esser; Stella Nyamoya; Simone C Tauber; Tim Clarner; Matthias B Stope; Thomas Pufe; Lars-Ove Brandenburg
Journal:  J Mol Neurosci       Date:  2017-05-02       Impact factor: 3.444

4.  Cuprizone feeding induces swollen astrocyte endfeet.

Authors:  Petra Fallier-Becker; Irina Bonzheim; Friederike Pfeiffer
Journal:  Pflugers Arch       Date:  2022-10-15       Impact factor: 4.458

5.  Evaluation strategy to determine reliable demyelination in the cuprizone model.

Authors:  Uta Chrzanowski; Christoph Schmitz; Anja Horn-Bochtler; Anne Nack; Markus Kipp
Journal:  Metab Brain Dis       Date:  2019-01-03       Impact factor: 3.584

6.  Nrf2 deficiency increases oligodendrocyte loss, demyelination, neuroinflammation and axonal damage in an MS animal model.

Authors:  Anna Nellessen; Stella Nyamoya; Adib Zendedel; Alexander Slowik; Christoph Wruck; Cordian Beyer; Athanassios Fragoulis; Tim Clarner
Journal:  Metab Brain Dis       Date:  2019-09-16       Impact factor: 3.584

7.  Stereological Investigation of Regional Brain Volumes after Acute and Chronic Cuprizone-Induced Demyelination.

Authors:  Tanja Hochstrasser; Sebastian Rühling; Kerstin Hecher; Kai H Fabisch; Uta Chrzanowski; Matthias Brendel; Florian Eckenweber; Christian Sacher; Christoph Schmitz; Markus Kipp
Journal:  Cells       Date:  2019-09-03       Impact factor: 6.600

8.  Increased blood-brain barrier hyperpermeability coincides with mast cell activation early under cuprizone administration.

Authors:  John Shelestak; Naveen Singhal; Lana Frankle; Riely Tomor; Sarah Sternbach; Jennifer McDonough; Ernest Freeman; Robert Clements
Journal:  PLoS One       Date:  2020-06-08       Impact factor: 3.240

Review 9.  The Cuprizone Model: Dos and Do Nots.

Authors:  Jiangshan Zhan; Teresa Mann; Sarah Joost; Newshan Behrangi; Marcus Frank; Markus Kipp
Journal:  Cells       Date:  2020-03-31       Impact factor: 6.600

10.  Transplantation of induced neural stem cells (iNSCs) into chronically demyelinated corpus callosum ameliorates motor deficits.

Authors:  Genevieve M Sullivan; Andrew K Knutsen; Luca Peruzzotti-Jametti; Alexandru Korotcov; Asamoah Bosomtwi; Bernard J Dardzinski; Joshua D Bernstock; Sandra Rizzi; Frank Edenhofer; Stefano Pluchino; Regina C Armstrong
Journal:  Acta Neuropathol Commun       Date:  2020-06-09       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.